Navigation Links
WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals
Date:11/20/2008

SAN FRANCISCO, Nov. 20 /PRNewswire/ -- WWMR, Inc., the marketing research leader in pain, announces results of the first annual "Most Appreciated Pain Drug Company Survey". The top three most appreciated companies are Pfizer, Eli Lilly and Endo Pharmaceuticals, according to the 100 pain clinic physicians surveyed in September 2008. These companies are most noted for their knowledgeable, respectful and informed sales representatives, their sampling/voucher plans, and their educational resources, as well as their drug products.

"While Pfizer, Lilly and Endo may be the most appreciated companies among many of the surveyed pain clinicians, there is plenty of opportunity for others to enhance their company image," stated Susan Olsen, President of WWMR, Inc. "A notable proportion of the pain clinicians surveyed noted that they don't appreciate any pain drug companies, and we view this is an opportunity waiting." Clients subscribing to the Pain Clinic Monitor have full access to this company image information, which outlines opportunities for companies to develop positive relationships with clinicians, and profiles competing companies.

Launched in January 2008, the Pain Clinic Monitor provides deep insights into the treatment of pain clinic-based chronic pain patients. The Pain Clinic Monitor provides a long-awaited perspective on the treatment of more than 10,000 patients with 27 different pain conditions. Information is available on in-office treatments as well as on up to seven pain drugs a patient has been prescribed, including why prescribed drugs have been tried, switched and discontinued.

The Pain Clinic Monitor is a monthly audit of a carefully balanced sample of 100 academic and nonacademic, office-based pain clinics, with each reporting treatment details for 10 patients. It is the basis for the 27 pain condition profiles provided as part of the Monitor. Companies, drug products and detailing messages are also captured, as the clinicians report on detailing visits for up to five company sales representatives each month.

"There has been a major gap in resources that report to the biotech, pharmaceutical and medical device industries about prescription drug use and pharmaceutical marketing in pain clinics. The Pain Clinic Monitor is designed to fill this gap. The Pain Clinic Monitor presents a fresh, unique focus on point of care pain prescribing, and a significant opportunity to obtain actionable findings for Product Development, as well as Marketing and Physician Education professionals," stated Susan Olsen, President, WWMR. "There are no other comparable audits available to companies focused on the treatment of pain."

Some of the reasons companies subscribe to the Pain Clinic Monitor include:

    1.  Provides insights from a 10,000 pain-patient database;
    2.  Understanding drug use for 27 different pain conditions;
    3.  Monitor uptake of NEW pain drugs;
    4.  Track reasons for pain drug discontinuations;
    5.  Examine in-office (IV, injectable, oral and topical) pain drug
        administrations;
    6.  Know all the pain drugs a given chronic pain patient is taking;
    7.  Analyze pain drug detailing & detailing messages;
    8.  Profile competitive pain drug uses;
    9.  Connect with the most influential clinicians prescribing for chronic
        pain patients;
    10. Ask ad-hoc questions of a representative panel of pain center
        clinicians;
    11. Support their company's product development, marketing, and physician
        education efforts in the pain therapy area; and
    12. Receive the results of the annual "Most Appreciated Pain Drug Company
        Survey.

WWMR, Inc. is a marketing research and strategic consulting and publishing firm with global capabilities, known for conducting focused and solution-oriented research across all phases of drug development. In addition to offering the Pain Clinic Monitor, the firm continues to expand its line of pain-related, multi-client Enhanced Perspective publications, with its 2008 U.S. Neuropathic Pain Report, featuring two new chapters -- Fibromyalgia and Neuropathic Cancer Pain. Two additional pain-related reports are scheduled to be available soon: Cancer Pain in December 2008 and Back Pain in January 2009. With an experienced staff of consultants and analysts, WWMR, Inc. continues to demonstrate its commitment to providing cost-effective business decision support to pharmaceutical, biotech, medical device and diagnostics clients who want to optimize the revenue potential of their product portfolio through effective business decisions.

For more information about the Pain Clinic Monitor and other services provided by WWMR, Inc., please contact Michelle Nordstrom, Office and Production Manager at the Corporate Headquarters:

     WWMR, Inc.
     2929 Campus Drive
     Suite 200
     San Mateo, CA 94403
     Phone: (888) 947-2339
            (650) 513-0300
     Fax:   (650) 312-1570
     Web:  http://www.WWMR.com
     Email: Michelle_Nordstrom@WWMR.com

'/>"/>
SOURCE WWMR, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Wound Management Technologies, Inc. Announces a Published Case Study
2. Histogen Announces Start of Hair Regrowth Clinical Evaluation
3. New Generation Biofuels Announces Test Burn Agreement With Progress Energy Florida
4. KGI Announces Second Annual Executive Education Conference for Women in Life Sciences
5. SyntheMed Announces FDA Clearance of SinusShield(TM)
6. Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit
7. American HealthChoice Announces the First Sales of the OmniBody Scan
8. Tengion Announces Second Closing of Series C Financing
9. Penguin Computing Announces Niveus HTX Personal Supercomputer
10. Convey Computer™ Corporation Announces First Customer: University of California, San Diego at SC08 Conference
11. BBM Announces Offer to Acquire YM BioSciences Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):